PS Ratio Chart

Historical PS Ratio Data

View and export this data back to 2021. Start Trial.
Date Value
November 16, 2026 0.2701
November 13, 2026 0.2676
November 12, 2026 0.2776
November 11, 2026 0.3085
November 10, 2026 0.3064
November 09, 2026 0.344
November 06, 2026 0.3828
November 05, 2026 0.6477
November 04, 2026 0.6962
November 03, 2026 0.6081
November 02, 2026 0.6037
October 30, 2026 0.6213
October 29, 2026 0.6279
October 28, 2026 0.6169
October 27, 2026 0.6235
October 26, 2026 0.6389
October 23, 2026 0.6257
October 22, 2026 0.6037
October 21, 2026 0.6037
October 20, 2026 0.6125
October 19, 2026 0.5949
October 16, 2026 0.5728
October 15, 2026 0.6125
October 14, 2026 0.5905
October 13, 2026 0.5993
Date Value
October 12, 2026 0.6522
October 09, 2026 0.6962
October 08, 2026 0.7403
October 07, 2026 0.7359
October 06, 2026 0.7138
October 05, 2026 0.6874
October 02, 2026 0.683
October 01, 2026 0.6742
September 30, 2026 0.7711
September 29, 2026 1.131
September 28, 2026 1.114
September 25, 2026 1.161
September 24, 2026 1.088
September 23, 2026 1.170
September 22, 2026 1.243
September 21, 2026 1.277
September 18, 2026 1.307
September 17, 2026 1.290
September 16, 2026 1.299
September 15, 2026 1.290
September 14, 2026 1.290
September 11, 2026 1.239
September 10, 2026 1.23
September 09, 2026 1.217
September 08, 2026 1.260

Price to Sales Ratio Definition

The Price to Sales Ratio (PS Ratio) is calculated by taking the stock price / revenue per share (ttm). This metric is considered a valuation metric that confirms whether the sales of a company justifies the stock price. There isn't necesarily an optimum PS ratio, since different industries will have different ranges of PS Ratios. Because of this, PS Ratio is great to evaluate from a relative standpoint with other similar companies. PS Ratio might also be a handy metric for companies that are not profitable yet, since they might be valued moreso by their overall sales and potential of becoming profitable in the future.

Read full definition.

PS Ratio Range, Past 5 Years

View PS Ratio Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

PS Ratio Benchmarks

View PS Ratio Benchmarks
Start Trial
Stereotaxis, Inc. 2.530
Accuray, Inc. 0.0206
Orthofix Medical, Inc. 0.3307
ResMed, Inc. 6.030
Rockwell Medical, Inc. 0.3682

PS Ratio Related Metrics

Price to Book Value 1.264
Price 0.613
Earnings Yield -326.7%
Market Cap 17.46M